Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Aurora Cannabis (ACB) delivered earnings and revenue surprises of +200.00% and +2.88%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Aurora Cannabis ( (TSE:ACB)) has provided ...

Vingroup group accelerates, VN-Index increases beyond 1,630 points; Ho Chi Minh City: Newly established enterprises decrease ...

Stock market rebounds slightly, liquidity remains low; Fed official predicts stablecoin boom could lead to lower interest ...

They define one of the boundaries of my spring dreams, inspiring me with speckled Rembrandt varieties, Darwin hybrids with ...

Nvidia chief executive Jensen Huang has issued a stark warning that China “is going to win” the race to develop ...

Waltzing and Contra Dance — Waltzing 7-7:45, Contra dance intro session at 7:45 p.m. and Contra Dance 8-11 p.m.. Regular dance admission plus $5 for waltz session. Beginners, singles, and all ages are ...

Aurora Cannabis reports Q2-2026 revenue growth with stronger international sales but posts net loss and negative free cash flow. Learn why ACB stock is a hold.

Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis sales.

TLRY posts a sharp profitability turnaround in Q1 as cost control, efficiency gains and portfolio optimization boost results.